secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lunai Bioworks Inc. (LNAI)
CIK:        0001527728
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001731122-24-001372
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Renovaro seeks strategic investors for up to 20% of subsidiary Cube
-------------------------------------------------------------------

- Board intends to offer up to 20% ownership in RenovaroCube, a wholly owned molecular data science subsidiary.
- Cube uses proprietary AI for multi-omics analysis to accelerate precision medicine, starting with cancer.
- Proceeds from the offering expected to advance Cube's platform and go-to-market strategy.
- Subscription terms to be determined as investors are identified and approved by Renovaro's Board.
- RenovaroBio continues work on patented cancer vaccine targeting pancreatic, head and neck, liver tumors.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001372/0001731122-24-001372-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1527728/000173112224001372/e5928_8-k.htm
  HTML page:      https://secwatch.observer/filing/0001731122-24-001372

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer